View in EDS

Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.

Saved in:
Bibliographic Details
Title: Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.
Authors: Strathe A; Novo Nordisk A/S, Søborg, Denmark., Bomberg EM; Center for Pediatric Obesity Medicine and Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Jensch G; Novo Nordisk A/S, Søborg, Denmark., Kildegaard J; Novo Nordisk A/S, Søborg, Denmark., Harder-Lauridsen NM; Novo Nordisk A/S, Søborg, Denmark., Weghuber D; Paracelsus Medical University, Department of Pediatrics, Salzburg, Austria., Overgaard RV; Novo Nordisk A/S, Søborg, Denmark.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jun; Vol. 28 (6), pp. 4926-4934. Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41906858
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strathe+A%22">Strathe A</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Bomberg+EM%22">Bomberg EM</searchLink>; Center for Pediatric Obesity Medicine and Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Jensch+G%22">Jensch G</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Kildegaard+J%22">Kildegaard J</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Harder-Lauridsen+NM%22">Harder-Lauridsen NM</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Weghuber+D%22">Weghuber D</searchLink>; Paracelsus Medical University, Department of Pediatrics, Salzburg, Austria.<br /><searchLink fieldCode="AU" term="%22Overgaard+RV%22">Overgaard RV</searchLink>; Novo Nordisk A/S, Søborg, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2026 Jun; Vol. 28 (6), pp. 4926-4934. <i>Date of Electronic Publication: </i>2026 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41906858
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dom.70678
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4926
    Titles:
      – TitleFull: Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strathe A
      – PersonEntity:
          Name:
            NameFull: Bomberg EM
      – PersonEntity:
          Name:
            NameFull: Jensch G
      – PersonEntity:
          Name:
            NameFull: Kildegaard J
      – PersonEntity:
          Name:
            NameFull: Harder-Lauridsen NM
      – PersonEntity:
          Name:
            NameFull: Weghuber D
      – PersonEntity:
          Name:
            NameFull: Overgaard RV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1463-1326
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Diabetes, obesity & metabolism
              Type: main
ResultId 1